Music therapy is a clinical intervention in which musical experiences are used intentionally, within a therapeutic relationship and with defined goals, by a trained professional. This definition should be distinguished from simple exposure to recorded music, independent listening, recreational singing or “music medicine” interventions in which music is delivered without an individualized music-therapy process. The distinction matters because studies in depression include highly heterogeneous interventions, and results from one approach cannot automatically be attributed to others.
Systematic reviews and randomized trials suggest that music therapy, particularly as an adjunct to usual treatment, may reduce depressive symptoms in the short term and improve outcomes such as anxiety, functioning or quality of life in some populations. However, certainty of the evidence remains limited by protocol heterogeneity, often small sample sizes, difficulty blinding participants and therapists, variability of comparators and scarcity of long-term follow-up. There is therefore no scientific basis for replacing established effective antidepressant treatments with music therapy when those treatments are indicated.
A session may use active approaches, in which the patient produces music using voice, instruments, improvisation, composition or songwriting, and receptive approaches, in which listening is integrated with exploration of emotions, imagery, memories and personal meanings. Many programs combine the two approaches. The goal is not the aesthetic quality of performance, and prior musical skills are not required: music functions as a medium for expression, regulation, communication and therapeutic work.
In the treatment of depression, goals may include increasing behavioral activation, accessing and modulating emotions, reducing isolation, developing nonverbal expression, increasing self-efficacy and social participation. In an individual setting, the therapist can adapt structure, intensity and musical content to the patient’s energy level and mentalizing capacity; in groups, synchronization, belonging and interpersonal feedback may add further therapeutic processes.
Recorded music selected by the patient may have beneficial effects on mood or stress, but it does not automatically constitute music therapy. Community singing and other musical activities may also improve well-being and symptoms in some populations, as suggested by trials in older adults, but they are different interventions in terms of structure, dose and social mechanisms. A clinical page should therefore always specify which intervention was studied.
Music engages auditory, motor, attentional, memory, autonomic and reward systems. Listening to salient music can modulate arousal, expectancy and pleasure and interact with mesolimbic dopaminergic circuits; rhythm and synchronization may facilitate movement and interpersonal coordination; melodies associated with autobiographical experiences can evoke memories and affective states with an immediacy not always achievable through verbal language.
From a psychological perspective, the process may promote emotion regulation, symbolic expression, narrative restructuring and reduced avoidance. In patients with marked anhedonia, graded engagement with meaningful musical experiences can function as a form of activation and rediscovery of reinforcing experiences. In groups, making music together adds a social component that may counter withdrawal and loneliness.
These mechanisms are plausible but should not be turned into definitive causal explanations. Reductions in cortisol, autonomic changes or neuroimaging activations observed in experimental studies do not demonstrate that a single pathway mediates the antidepressant effect. Musical preferences, personal history, culture, familiarity and context can also radically alter the response to the same music.
The 2017 Cochrane review concluded that adding music therapy to treatment as usual may improve depressive symptoms in the short term compared with treatment as usual alone, but with limitations related to the number and quality of studies. Subsequent meta-analyses confirmed an overall favorable signal while highlighting substantial heterogeneity across active music therapy, receptive music therapy, music listening, session frequency and patient characteristics.
The Finnish trial by Erkkilä and colleagues showed that individual improvisational music therapy added to standard care improved depression, anxiety and functioning at three months compared with standard care alone. Studies in older adults have observed benefits with structured listening or singing activities, but these populations have different goals and contexts from adults with major depressive disorder treated in specialist settings.
A 2025 meta-analysis specifically focused on randomized trials in patients with depression found a favorable effect of music therapy but rated the certainty of the evidence as very low for several outcomes, emphasizing the need for larger trials, replicably described interventions and longer follow-up. A recent group trial in women with major depression also provided contemporary data on symptoms and functional outcomes, but a single study does not resolve the variability of the entire field.
Dose-response analyses suggest that a greater number of sessions may be associated with larger effects in people with severe mental disorders, but there is no universal “antidepressant dose.” Optimal frequency depends on the type of intervention and cannot be inferred by pooling nonequivalent protocols. It is therefore more appropriate to monitor achievement of clinical goals than to prescribe a context-free standard number of sessions.
Care should begin with a clinical assessment of depression rather than musical preference. Severity, suicide risk, psychotic symptoms, history of mania or hypomania, substance use, cognitive deficits, neurological conditions and ongoing treatments determine priorities and setting. Music therapy can be added when the patient is able to participate and its goals are compatible with the overall treatment plan.
Music-therapy assessment explores the patient’s relationship with music, meaningful genres, formative experiences, possible traumatic associations, willingness to engage in vocal or instrumental expression, and preference for individual or group approaches. Personalization is particularly important because the same music may be comforting for one patient and intensely painful for another. The therapist should also avoid imposing repertoire based on age-related or cultural stereotypes.
Outcomes should be measured with appropriate instruments: in addition to changes in depressive symptoms, functioning, anhedonia, anxiety, isolation, quality of life, adherence to other treatments and ability to participate may be relevant. Benefit perceived during a session should not be confused with sustained clinical improvement.
Music therapy is generally a low-physical-risk intervention, but it is not free of possible adverse effects. Music associated with bereavement, trauma or relationships may evoke intense emotions, intrusive memories or dissociation. Excessive volume can damage hearing; very intense rhythms or stimulation may be overwhelming for people with sensory hypersensitivity, headache or certain neurological conditions.
In mood disorders, unusual changes in activation, sleep and behavior should also be monitored. There is no evidence that standard music therapy commonly induces mania, but in a person with bipolar vulnerability, increased activation should be interpreted clinically rather than automatically celebrated as improvement. In groups, consent, confidentiality and the option not to share personal material evoked by music must be protected.
The most rational role for music therapy is as a structured complementary treatment, particularly when the patient is interested in the modality, has difficulty with verbal expression, is socially isolated, or needs an additional channel for activation and relationship. It can be integrated with psychotherapy, pharmacotherapy, rehabilitation and psychosocial interventions without creating a false dichotomy between “medical” and “creative” care.
The prognosis of response is difficult to predict. Musical preference and engagement may support adherence but are not biomarkers of efficacy. Current literature supports the possibility of symptomatic benefit, not the idea that music has a uniform antidepressant effect independent of therapeutic context. High-quality clinical practice therefore requires explicit goals, a competent professional, outcome measurement, and willingness to modify or discontinue the intervention if it provides no benefit.
In practice, the most reasonable indication is an adjunctive intervention when the patient is interested in music and the service has a trained professional, with measurable goals and coordination with psychiatric treatment. Optimal frequency, number of sessions and persistence of effect are not defined with the precision available for many pharmacological therapies; moreover, studies use highly heterogeneous protocols. Response should therefore be assessed through symptoms, functioning, social participation and quality of life, and the intervention should be modified or discontinued if it produces no observable benefit. The absence of pharmacological toxicity does not justify using it as a substitute for effective treatments in severe depression.
Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.
Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.